南微医学：2025年前三季度，公司欧盟出口业务收入在整体营收中的占比约为26.8%

Group 1 - The company has established wholly-owned subsidiaries for direct sales in several EU countries, including Germany, the UK, France, the Netherlands, Portugal, and Switzerland, while adopting a distribution model in other EU nations [2] - The company completed the acquisition of 51% of the Spanish company CreoMedical S.L.U. in February 2025, which enhances its sales channels for medical devices in Western Europe, primarily focusing on direct sales [2] - In the first three quarters of 2025, the company's export revenue from the EU accounted for approximately 26.8% of its total revenue, including the consolidation of CME [2]